ロード中...
HIVAN and medication use in chronic dialysis patients in the United States: analysis of the USRDS DMMS Wave 2 study
BACKGROUND: The use and possible effects of factors known to improve outcomes in patients with human immunodeficiency virus associated nephropathy (HIVAN), namely of angiotensin converting enzyme inhibitors (ACE) and antiretroviral therapy, has not been reported for a national sample of dialysis pat...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2003
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC166168/ https://ncbi.nlm.nih.gov/pubmed/12837135 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2369-4-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|